• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国免费抗逆转录病毒治疗项目的当前进展。

Current progress of China's free ART program.

作者信息

Zhang Fu Jie, Pan Jennifer, Yu Lan, Wen Yi, Zhao Yan

机构信息

National Center for STD/AIDS Prevention and Control, Beijing 100050, China.

出版信息

Cell Res. 2005 Nov-Dec;15(11-12):877-82. doi: 10.1038/sj.cr.7290362.

DOI:10.1038/sj.cr.7290362
PMID:16354563
Abstract

China's Free ART Program was initiated in 2002 as an emergency response to save and improve the lives of AIDS patients living mainly in impoverished rural regions of central China. With little experience in HIV/AIDS treatment and care and resource limitations, China's efforts to provide widespread access to free antiretroviral therapy has been a process fraught with difficulty. However, the Free ART Program is progressing from an emergency response to a standardized treatment and care system. The development of national guidelines, training programs, a laboratory support network, a national patient database, programs for special populations such as children and patients living with co-infections, and operational research has improved the scope and quality of the free treatment program. As of June 30, 2005, a total of 19,456 patients in 28 provinces, autonomous regions, and special municipalities had received free ART. Challenges stemming from the nature of China's health system and patient population persist, but with strong government support and a diverse set of resources, China has the capacity to overcome these challenges and to provide nationwide access to high quality treatment and care.

摘要

中国免费抗逆转录病毒治疗项目于2002年启动,作为一项应急措施,旨在挽救并改善主要生活在中国中部贫困农村地区艾滋病患者的生命。由于在艾滋病毒/艾滋病治疗与护理方面经验匮乏且资源有限,中国在广泛提供免费抗逆转录病毒治疗方面的努力充满困难。然而,免费抗逆转录病毒治疗项目正从应急措施向标准化治疗与护理体系迈进。国家指南、培训项目、实验室支持网络、国家患者数据库、针对儿童及合并感染患者等特殊人群的项目以及运营研究的发展,改善了免费治疗项目的范围与质量。截至2005年6月30日,28个省、自治区和直辖市共有19456名患者接受了免费抗逆转录病毒治疗。源于中国卫生系统性质和患者群体的挑战依然存在,但在政府的大力支持和多种资源的共同作用下,中国有能力克服这些挑战,并在全国范围内提供高质量的治疗与护理。

相似文献

1
Current progress of China's free ART program.中国免费抗逆转录病毒治疗项目的当前进展。
Cell Res. 2005 Nov-Dec;15(11-12):877-82. doi: 10.1038/sj.cr.7290362.
2
Progress of the National Pediatric Free Antiretroviral Therapy program in China.中国国家儿童免费抗逆转录病毒治疗项目进展
AIDS Care. 2010 Oct;22(10):1182-8. doi: 10.1080/09540121003615129.
3
The Chinese free antiretroviral treatment program: challenges and responses.中国免费抗逆转录病毒治疗项目:挑战与应对措施
AIDS. 2007 Dec;21 Suppl 8:S143-8. doi: 10.1097/01.aids.0000304710.10036.2b.
4
Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.对马拉维抗逆转录病毒治疗快速推广的国家监测与评估系统的评估。
Trop Med Int Health. 2007 Mar;12(3):377-81. doi: 10.1111/j.1365-3156.2006.01800.x.
5
[Impact of access to antiretroviral therapy in Côte d'Ivoire].[抗逆转录病毒疗法可及性对科特迪瓦的影响]
Med Trop (Mars). 2009 Oct;69(5):520-4.
6
Expansion of China's free antiretroviral treatment program.中国扩大免费抗逆转录病毒治疗计划。
Chin Med J (Engl). 2012 Oct;125(19):3514-21.
7
Overview of antiretroviral treatment in China: advancement and challenges.中国抗逆转录病毒治疗概述:进展与挑战。
Chin Med J (Engl). 2011 Feb;124(3):440-4.
8
Care of HIV-infected patients in China.中国艾滋病毒感染患者的护理。
Cell Res. 2005 Nov-Dec;15(11-12):883-90. doi: 10.1038/sj.cr.7290363.
9
Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?中国艾滋病治疗的自付费用:免费抗逆转录病毒药物是否足够?
AIDS Care. 2008 Sep;20(8):984-94. doi: 10.1080/09540120701768446.
10
Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.南非自由邦省的公共部门抗逆转录病毒治疗:社区支持是治疗结果的重要决定因素。
Soc Sci Med. 2009 Oct;69(8):1177-85. doi: 10.1016/j.socscimed.2009.07.034. Epub 2009 Aug 18.

引用本文的文献

1
Effect of a WeChat-Based Hybrid Intervention on the Adaptation Outcomes of People Living With HIV/AIDS: Pilot Randomized Controlled Trial.基于微信的混合干预对艾滋病毒/艾滋病感染者适应结果的影响:试点随机对照试验
J Med Internet Res. 2025 Apr 3;27:e65268. doi: 10.2196/65268.
2
Analysis of the immunological response to antiviral therapy in patients with different subtypes of HIV/AIDS: a retrospective cohort study.分析不同亚型 HIV/AIDS 患者抗病毒治疗的免疫反应:一项回顾性队列研究。
BMJ Open. 2024 May 15;14(5):e072597. doi: 10.1136/bmjopen-2023-072597.
3
Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China.
中国天津的治疗前整合酶链转移抑制剂耐药情况。
Chin Med J (Engl). 2023 Nov 20;136(22):2735-2737. doi: 10.1097/CM9.0000000000002898. Epub 2023 Nov 3.
4
Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020.中国北京 2010-2020 年 HIV 感染者延迟和晚期开始抗逆转录病毒治疗的相关因素。
Int J Public Health. 2023 Jun 21;68:1605824. doi: 10.3389/ijph.2023.1605824. eCollection 2023.
5
Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz + lamivudine + tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China.在中国湖南省新开始接受治疗的 HIV-1 患者中,比克替拉韦/恩曲他滨/丙酚替诺福韦和依非韦伦+拉米夫定+富马酸替诺福韦二吡呋酯的治疗持续时间。
BMC Infect Dis. 2023 Jun 12;23(1):396. doi: 10.1186/s12879-023-08359-w.
6
Temporal trends in inequalities of the burden of HIV/AIDS across 186 countries and territories.186 个国家和地区艾滋病毒/艾滋病负担不平等的时间趋势。
BMC Public Health. 2023 May 26;23(1):981. doi: 10.1186/s12889-023-15873-8.
7
Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, China.中国西安未经治疗的 HIV 感染者的遗传多样性和耐药特征。
Drug Des Devel Ther. 2023 May 17;17:1485-1494. doi: 10.2147/DDDT.S406255. eCollection 2023.
8
Peer-Led Community-Based Support Services and HIV Treatment Outcomes Among People Living With HIV in Wuxi, China: Propensity Score-Matched Analysis of Surveillance Data From 2006 to 2021.基于同伴引领的社区支持服务与中国无锡市 HIV 感染者的治疗结局:基于 2006 年至 2021 年监测数据的倾向评分匹配分析。
JMIR Public Health Surveill. 2023 Mar 24;9:e43635. doi: 10.2196/43635.
9
Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021.2018年至2021年南京市HIV传播耐药性的流行情况。
Infect Drug Resist. 2023 Feb 2;16:735-745. doi: 10.2147/IDR.S391296. eCollection 2023.
10
Trends in rates and causes of hospitalization among people living with HIV in the antiretroviral therapy era: A retrospective cohort study in China, 2008-2020.抗逆转录病毒治疗时代中国 HIV 感染者住院率及住院原因的变化趋势:一项回顾性队列研究,2008-2020 年。
Front Public Health. 2022 Nov 8;10:1000942. doi: 10.3389/fpubh.2022.1000942. eCollection 2022.